NCT00376805 2017-12-28
Allogeneic Natural Killer (NK) Cells in Patients With Advanced Metastatic Breast Cancer
Masonic Cancer Center, University of Minnesota
Phase 2 Terminated
Masonic Cancer Center, University of Minnesota
Fred Hutchinson Cancer Center
Stanford University
National Cancer Institute (NCI)